Detalhe da pesquisa
1.
Desvenlafaxine for the prevention of relapse in major depressive disorder: results of a randomized trial.
J Clin Psychopharmacol
; 30(1): 18-24, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20075643
2.
Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial.
Int Clin Psychopharmacol
; 23(5): 243-53, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18703933
3.
A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder.
Int Clin Psychopharmacol
; 23(4): 188-97, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18545056
4.
Bipolar disorder: how far are we from a rigorous definition and effective management?
Prog Neuropsychopharmacol Biol Psychiatry
; 31(5): 975-96, 2007 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-17459551
5.
Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Clin Ther
; 31 Pt 1: 1405-23, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19698901